Evaluation of insulin resistance, tumor necrosis factor alpha, and total antioxidant status in obese patients smoking cigarettes

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 14, 2013, Pages 1916-1922

  Szulinska, M ^a   Piorunek, T ^a   Suliburska, J ^b   Pupek Musialik, D ^a   Kupsz, J ^a   Drzymala Czyz, S ^a   Bogdanski, P ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Inflammation; Insulin resistance; Obesity; Smoking

Indexed keywords

ANTIOXIDANT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TUMOR NECROSIS FACTOR ALPHA; LIPID;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; EVALUATION; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; OBESITY; PATHOGENESIS; SMOKING; ANTHROPOMETRY; BLOOD; BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; ANTHROPOMETRY; ANTIOXIDANTS; BLOOD GLUCOSE; BLOOD PRESSURE; FEMALE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; OBESITY; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884262197     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. HINNOUHO G, CZERNICHOW S, DUGRAVOT A, BATTY GD, KIVIMAKI M, SINGH-MANOUX A. Metabolically healthy obesity and risk of mortality: Does the definition of metabolic health matter? Diabetes Care 2013; Epub ahead of print.
2. SCHROEDER S. Smoking-related mortality in the United States. N Engl J Med 2013; 368: 1753-1754.
3. GREENBERG JA. Obesity and early mortality in the United States. Obesity 2013; 21: 405-412.
4. PEETERS A, BARENDREGT J, WILLEKENS F, MACKENBACH J , AL MAMUN A, BONNEUX L; NEDCOM, THE NETHERLANDS EPIDEMIOLOGY AND DEMOGRAPHY COMPRESSION OF MORBIDITY RESEARCH GROUP. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003; 138: 24-32.
5. JOHN U, HANKE M, RUMPF H, THYRIAN J. Smoking status, cigarettes per day, and their relationship to overweight and obesity among former and current smokers in a national adult general population sample. Int J Obes Relat Metab Disord 2005; 29: 1289-1294.
6. CHIOLERO A, JACOT-SADOWSKI I, FAEH D, PACCAUD F, CORNUZ J. Association of cigarettes daily smoked with obesity in a general European adult population. Obes Res 2007; 15: 1311-1318.
7. SHIMOKATA H, MULLER D, ANDRES R. Studies in the distribution of body fat. III. Effects of cigarette smoking. JAMA 1989; 261: 1169-1173.
8. ISTVAN J, CUNNINGHAM T, GARFINKEL L. Cigarette smoking and body weight in the Cancer Prevention Study I. Int J Epidemiol 1992; 21: 849- 853.
9. RASKY E, STRONEGGER W, FREIDL W. The relationship between body weight and patterns of smoking in women and men. Int J Epidemiol 1996; 25: 1208- 1212.
10. LIU Z. Molecular mechanism of TNF signaling and beyond. Cell Res 2005; 15: 24-27.
11. SAFARDIS P, GRECAS D. Insulin resistance and oxidant stress: an interrelation with deleterious renal consequences? J Cardiomet Syndr 2007; 2: 139-142.
12. MANABE I. Inflammatory process in atherosclerosis. Nihon Rinsho 2011; 69: 13-17.
13. MILLER-KASPRZAK E, BOGDANSKI P, PUPEK-MUSIALIK D, JAGODZISKI PP. Insulin resistance and oxidative stress influence colony-forming unit-endothelial cells capacity in obese patients. Obesity 2011; 19: 736-742.
14. MATTHEWS D, HOSKER J, RUDENSKI A, NAYLOR B, TREACHER D, TURNER R. Homeostasis model assessment: insulin resistance and beta cell function from fasting glucose and insulin concentration in man. Diabetologia 1985; 28: 412-419.
15. MEIGS J, WILSON P, FOX C, VASAN R, NATHAN D, SULLIVAN L, D'AGOSTINO R. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906-2912.
16. BLOOMGARDEN Z. Cardiovascular complications of insulin resistance. Metab Syndr Relat Disord 2005; 3: 305-315.
17. AL ZADJALI M, GODFREY V, KHAN F, CHOY A, DONEY A, WONG A, PETRIE J, STRUTHERS A, LANG C. Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. J Am Coll Cardiol 2009; 53: 747-753.
18. WAGENKNECHT L, ZACCARO D, ESPELAND M, KARTER A, O'LEARY D, HAFFNER S. Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol 2003; 23: 1035-1041.
19. ROGERO BLANCO M. Prevalence of insulin resistance in a young adult population. relationship with weight status. Endocrinol Nutr 2012, 59: 98- 104.
20. WEITZMAN M, COOK S, AUINGER P. Tobacco smoke exposure is associated with the metabolic syndrome in adolescents. Circulation 2005; 112: 862-869.
21. YOSHIDA T, SAKANE N, UMEKAWA T. Nicotine induces uncoupling protein 1 in white adipose tissue of obese mice. Int J Obes Relat Metab Disord 1999; 23: 570 -575.
22. CANOY D, WAREHAM N, LUBEN R. Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obes Res 2005; 13: 1466 -1475.
23. LEITE ML, NICOLOSI A. Lifestyle correlates of anthropometric estimates of body adiposity in an Italian middle-aged and elderly population: a covariance analysis. Int J Obes 2006; 30: 926 -934.
24. JEE SH, LEE SY, NAM CM, KIM SY, KIM MT. Effect of smoking on the paradox of high waist-to-hip ratio and low body mass index. Obes Res 2002; 10: 891-895.
25. HAN TS, SATTAR N, LEAN M. ABC of obesity. Assessment of obesity and its clinical implications. Br Med J 2006; 333: 695-698.
26. FANTUZZI G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005; 115: 911-919.
27. HOTAMISLIGIL GS, ARNER P, ATKINSON RL. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 1997; 46: 451-455.
28. CYMERYS M, BOGDASKI P, PUPEK-MUSIALIK D, JABLECKA A, LACKI J, KORCZOWSKA I, DYTFELD J. Influence of hypertension, obesity and nicotine abuse on quantitative and qualitative changes in acute-phase proteins in patients with essential hypertension. Med Sci Monit 2012; 18: 330-336.
29. LIND P, ENGSTROM G, STAVENOW L, JANZON L, FINDGRADE F, HEDBLAD B. Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins. Arterioscler Tromb Vasc Biol 2004; 24: 577-582.
30. WILLI C, BODENMANN P, GHALI WA, FARIS PD, CORNUZ J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007; 298: 2654-64.
31. XU T, HOLZAPFEL C, DONG X. Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med 2013; 11: 60.
32. YUDKIN JS, ERINGA E, STEHOUWER CD. Vasocrine signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005; 365: 1817-1820.
33. CHOY JC, GRANVILLE DJ, HUNT DW. Endothelial cell apoptosis: biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 2001; 33: 1673-1690.
34. UYSAL KT, WIESBROCK SM, MARINO MW, HOTAMISLIGIL GS. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389: 610-614.
35. DANDONA P, WEINSTOCK R, THUSU K, ABDEL-RAHMAN E, ALJADA A, WADDEN T. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 1998; 83: 2907-2910.
36. OLSON NC, CALLAS PW, HANLEY AJ, FESTA A, HAFFNER SM, WAGENKNECHT LE, TRACY RP. Circulating levels of TNF-are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis Study. J Clin Endocrinol Metab 2012; 97: 1032- 1040.
37. D'ODORICO A, MARTINES D, KIECHL S, EGGER G, OBERHOLLENZER F, BONVICINI P. High plasma levels of alpha- and beta-carotene are associated with a lower risk of atherosclerosis: Results from the Bruneck study. Atherosclerosis 2000; 153: 231- 239.
38. EREL O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004; 37: 112-119.
39. RIGOTTI NA. Clinical practice. Treatment of tobacco use and dependence. N Engl J Med 2002; 346: 506 -512.
40. JEPPESEN J, HANSEN TW, RASMUSSEN S. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol 2007; 49: 2112-2119.
41. POOLING PROJECT RESEARCH GROUP. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary event: final report of the Pooling Project. J Chronic Dis 1978; 31: 201-306.
42. HOLLAND AT, PALANIAPPAN LP. Problems with the collection and interpretation of Asian-American health data: omission, aggregation, and extrapolation. Ann Epidemiol 2012; 22: 397-405.
43. FRIEDEN TR, BLOOMBERG MR. How to prevent 100 million deaths from tobacco. Lancet 2007; 369: 1758-1761.